Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy

Pascale Hubert(University of Liège), Michaël Herfs(University of Liège)
Journal for ImmunoTherapy of Cancer
March 1, 2021
Cited by 169


Related Papers